TLR7 and neoplasm: To address these issues, scientists have designed core–shell nanoparticles that are composed of an enzyme that can decompose H2O2 to generate O2 and a toll-like-receptor-7 agonist that can regulate the immune suppressive tumor microenvironment.(154).